Stay updated on the latest from Claria!

Exclusively Brought to You By MedGenome

UPCOMING EVENTS

20th November, 2018

The Advantages of prenatal 22q11.2 deletion syndrome and microdeletions screening

The Advantages of prenatal 22q11.2 deletion syndrome and microdeletions screening on 20th November 2018.

SPEAKERS

PAST EVENTS

10th September 2018

MedGenome Webinar: Clinical evidence supporting the use of Preimplantation Genetic Screening (PGS)

MedGenome In Association With Illumina/Premas Life Sciences presents a webinar on: Clinical evidence supporting the use of Preimplantation Genetic Screening (PGS)

Speaker: Speaker: Kathryn Gebhardt (PhD), Sr.Clinical IVF Specialist, Asia Pacific Japan, Illumina

SPEAKERS

Kathryn Gebhardt

Dr. Kathryn Gebhardt (PhD)

Sr.Clinical IVF Specialist

26th June 2018

Webinar: High Accuracy Screening for Twin Pregnancies by NIPT

As with singleton pregnancies, screening for aneuploidies non-invasively is very important for twins as well.
To address this priority MedGenome has recently launched Claria NIPT screening for twin/surrogate and egg donor pregnancies. In addition to aneuploidies, Claria NIPT can also detect the most common microdeletion syndrome, 22q11.2. Furthermore, zygosity can be determined accurately, thereby providing a reliable marker for triaging twin pregnancies for conditions such as growth restriction, twin to twin transfusion syndrome etc.

In this webinar we highlight the benefits of using Claria NIPT screening to accurately test for common chromosomal abnormalities, zygosity and individual fetal fractions for dizygotic twins. You will also learn about the importance of this information for better management of twin pregnancies.

18th January 2018, 5 pm to 6 pm.

Genetic Counselling: An Indispensable Step in Genetic Testing

Genetic Counselling is a professional approach to assess a patient’s or a couple’s genetic health, and the risk of passing on the disorder to the next generation. It takes into account their family, medical, and/or pregnancy history to advise them on the nature, outcomes, and probability of developing or transmitting the inherited disorders.

As the field of medicine becomes more complex through the growing use of genomic data, the need for genetic counselling is bound to increase. In the clinic post test genetic counselling can augment the role of the physician by helping patients interpret results and put them in the right context. Counselling helps to understand not only positive results, but also negative or ambiguous results, and to provide psychosocial support.

Dr Priya Kadam

Dr. Priya Kadam

Program Director, NIPT, Medgenome

Carrier Screening Test, Thursday, 9th November 2017, Time : 5 PM

A Webinar on Carrier Screening Test

Join Dr. Sheetal Sharda, Senior Consultant in Clinical Genomics, MedGenome Labs as she highlights:

  • Clinical conditions for offering Carrier Screening Test to families with case-based scenarios
  • The flaws of genotype and why NGS is a better method
  • Leveraging of the Indian genetic variant database to screen for genetic variations and diseases that are specific to the Indian population 
  • The benefits and limitations of the test
Sheetal Sharda

Dr. Sheetal Sharda

Pediatrician

Carrier Screening Test, Thursday, 9th November 2017, Time : 5 PM

A Webinar on Carrier Screening Test

Join Dr. Sheetal Sharda, Senior Consultant in Clinical Genomics, MedGenome Labs as she highlights:

  • Clinical conditions for offering Carrier Screening Test to families with case-based scenarios
  • The flaws of genotype and why NGS is a better method
  • Leveraging of the Indian genetic variant database to screen for genetic variations and diseases that are specific to the Indian population 
  • The benefits and limitations of the test
Sheetal Sharda

Dr. Sheetal Sharda

Pediatrician

Free Live Webinar on 20th September 2017, 5 pm to 6 pm

MedGenome Claria welcomes you to our exclusive webinar on "Antenatal screening for severe microdeletion syndromes by NIPT."

Non-Invasive prenatal testing (NIPT) has altered the landscape of prenatal chromosomal screening with robust results compared to traditional protocols. Recently, NIPT has expanded its scope to include sub-chromosomal anomaly tests like the 22q11.2 deletion syndrome, Angleman syndrome, Prader-Will, syndrome 1p36 and Cri-du-chat syndrome.

Join us on this webinar where we discuss a microdeletion clinical study as well as relevance of testing during prenatal period.

Dr Priya Kadam

Dr. Priya Kadam

Program Director, NIPT, Medgenome

Free Live Webinar on 18th August 2017, 4 to 5 pm

MedGenome Claria welcomes you to our exclusive webinar on "The Role of Preimplantation Genetic Screening/Diagnosis (PGS/D) in IVF."

In short,  the webinar will cover:

  • The techniques of PGS/D and their role in IVF pregnancies
  • The benefits of carrying out PGS and PGD will be discussed
  • How to select the best possible embryos for implantation
  • Understanding the impact of mosaic aneuploidy on implantation success rates
Dr Sham Balu

Dr. Sam Balu

Manager - Scientific Affairs (PGS/PGD)

Please fill out the form below to stay updated on our upcoming events